Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03769467
Title Tabelecleucel in Combination With Pembrolizumab in Subjects With EBV+ Nasopharyngeal Carcinoma (ATA129-NPC-202)
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Atara Biotherapeutics
Indications
Therapies
Age Groups: child | adult | senior
Covered Countries USA


No variant requirements are available.